RGNX Operating Cash Flow (Statement)
Regenxbio Inc · Operating Cash Flow (Statement)
RGNX Operating Cash Flow (Statement)
Latest reported-$62.24Mperiod ending
RGNX Quarterly Cash from Operations ($1.21M → -$62.24M)
Quarterly operating cash flow (statement)
High-resolution chart · PNG
RGNX operating cash flow (statement) history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Operating Cash Flow (Statement) (USD) |
|---|---|
| -62,238,000 | |
| -76,186,000 | |
| -52,290,000 | |
| -55,960,000 | |
| -49,342,000 | |
| 33,629,000 | |
| -31,624,000 | |
| -40,549,000 | |
| -45,497,000 | |
| -55,455,000 | |
| -40,760,000 | |
| -49,407,000 | |
| -47,322,000 | |
| -80,918,000 | |
| -39,372,000 | |
| -50,456,000 | |
| -61,749,000 | |
| -55,911,000 | |
| 326,237,000 | |
| -42,503,000 | |
| -29,872,000 | |
| -44,047,000 | |
| 39,468,000 | |
| -36,460,000 | |
| -21,496,000 | |
| -35,573,000 | |
| -25,506,000 | |
| -29,153,000 | |
| -23,749,000 | |
| -29,297,000 | |
| -4,140,000 | |
| -19,557,000 | |
| 70,211,000 | |
| 58,134,000 | |
| -13,826,000 | |
| -17,136,000 | |
| -9,549,000 | |
| -17,481,000 | |
| -20,423,000 | |
| -11,818,000 | |
| -8,430,000 | |
| -7,887,000 | |
| -4,443,000 | |
| -8,395,000 | |
| -8,002,000 | |
| -1,675,000 | |
| 138,000 | |
| -3,554,000 | |
| -196,000 | |
| 1,213,000 |